Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis.

Ershaid N, Sharon Y, Doron H, Raz Y, Shani O, Cohen N, Monteran L, Leider-Trejo L, Ben-Shmuel A, Yassin M, Gerlic M, Ben-Baruch A, Pasmanik-Chor M, Apte R, Erez N.

Nat Commun. 2019 Sep 26;10(1):4375. doi: 10.1038/s41467-019-12370-8.

2.

Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.

Liubomirski Y, Lerrer S, Meshel T, Morein D, Rubinstein-Achiasaf L, Sprinzak D, Wiemann S, Körner C, Ehrlich M, Ben-Baruch A.

Front Immunol. 2019 Apr 24;10:804. doi: 10.3389/fimmu.2019.00804. eCollection 2019.

3.

Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer.

Liubomirski Y, Lerrer S, Meshel T, Rubinstein-Achiasaf L, Morein D, Wiemann S, Körner C, Ben-Baruch A.

Front Immunol. 2019 Apr 12;10:757. doi: 10.3389/fimmu.2019.00757. eCollection 2019.

4.

Multi-disciplinary patient-centered model for the expedited provision of costly therapies in community settings: the case of new medication for hepatitis C.

Avisar N, Heller Y, Weil C, Ben-Baruch A, Potesman-Yona S, Oren R, Chodick G, Shalev V, Ash N.

Isr J Health Policy Res. 2017 Sep 28;6(1):46. doi: 10.1186/s13584-017-0172-1.

5.

Co-Inflammatory Roles of TGFβ1 in the Presence of TNFα Drive a Pro-inflammatory Fate in Mesenchymal Stem Cells.

Lerrer S, Liubomirski Y, Bott A, Abnaof K, Oren N, Yousaf A, Körner C, Meshel T, Wiemann S, Ben-Baruch A.

Front Immunol. 2017 May 11;8:479. doi: 10.3389/fimmu.2017.00479. eCollection 2017.

6.

miRNA-1246 induces pro-inflammatory responses in mesenchymal stem/stromal cells by regulating PKA and PP2A.

Bott A, Erdem N, Lerrer S, Hotz-Wagenblatt A, Breunig C, Abnaof K, Wörner A, Wilhelm H, Münstermann E, Ben-Baruch A, Wiemann S.

Oncotarget. 2017 Jul 4;8(27):43897-43914. doi: 10.18632/oncotarget.14915.

7.

Erratum to: Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.

Netanely D, Avraham A, Ben-Baruch A, Evron E, Shamir R.

Breast Cancer Res. 2016 Nov 28;18(1):117. No abstract available.

8.

Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.

Weitzenfeld P, Meshel T, Ben-Baruch A.

Oncotarget. 2016 Dec 6;7(49):81123-81143. doi: 10.18632/oncotarget.13213.

9.

Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.

Netanely D, Avraham A, Ben-Baruch A, Evron E, Shamir R.

Breast Cancer Res. 2016 Jul 7;18(1):74. doi: 10.1186/s13058-016-0724-2. Erratum in: Breast Cancer Res. 2016 Nov 28;18(1):117.

10.

Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors.

Weitzenfeld P, Kossover O, Körner C, Meshel T, Wiemann S, Seliktar D, Legler DF, Ben-Baruch A.

J Leukoc Biol. 2016 Jun;99(6):1009-25. doi: 10.1189/jlb.3MA0815-373R. Epub 2016 Mar 2.

PMID:
26936935
11.

Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.

Katanov C, Lerrer S, Liubomirski Y, Leider-Trejo L, Meshel T, Bar J, Feniger-Barish R, Kamer I, Soria-Artzi G, Kahani H, Banerjee D, Ben-Baruch A.

Stem Cell Res Ther. 2015 May 1;6:87. doi: 10.1186/s13287-015-0080-7.

12.

Breast cancer: coordinated regulation of CCL2 secretion by intracellular glycosaminoglycans and chemokine motifs.

Lebel-Haziv Y, Meshel T, Soria G, Yeheskel A, Mamon E, Ben-Baruch A.

Neoplasia. 2014 Sep;16(9):723-40. doi: 10.1016/j.neo.2014.08.004.

13.

The inflammatory cytokine TNFα cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cells.

Leibovich-Rivkin T, Liubomirski Y, Meshel T, Abashidze A, Brisker D, Solomon H, Rotter V, Weil M, Ben-Baruch A.

BMC Cancer. 2014 Mar 6;14:158. doi: 10.1186/1471-2407-14-158.

14.
15.

Progression of luminal breast tumors is promoted by ménage à trois between the inflammatory cytokine TNFα and the hormonal and growth-supporting arms of the tumor microenvironment.

Weitzenfeld P, Meron N, Leibovich-Rivkin T, Meshel T, Ben-Baruch A.

Mediators Inflamm. 2013;2013:720536. doi: 10.1155/2013/720536. Epub 2013 Dec 4.

16.

International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Bachelerie F, Ben-Baruch A, Burkhardt AM, Combadiere C, Farber JM, Graham GJ, Horuk R, Sparre-Ulrich AH, Locati M, Luster AD, Mantovani A, Matsushima K, Murphy PM, Nibbs R, Nomiyama H, Power CA, Proudfoot AE, Rosenkilde MM, Rot A, Sozzani S, Thelen M, Yoshie O, Zlotnik A.

Pharmacol Rev. 2013 Nov 11;66(1):1-79. doi: 10.1124/pr.113.007724. Print 2014. Review. Erratum in: Pharmacol Rev. 2014 Apr;66(2):467.

17.

The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer.

Weitzenfeld P, Ben-Baruch A.

Cancer Lett. 2014 Sep 28;352(1):36-53. doi: 10.1016/j.canlet.2013.10.006. Epub 2013 Oct 18. Review.

PMID:
24141062
18.

Mechanisms regulating the secretion of the promalignancy chemokine CCL5 by breast tumor cells: CCL5's 40s loop and intracellular glycosaminoglycans.

Soria G, Lebel-Haziv Y, Ehrlich M, Meshel T, Suez A, Avezov E, Rozenberg P, Ben-Baruch A.

Neoplasia. 2012 Jan;14(1):1-19.

19.

Tumor-promoting circuits that regulate a cancer-related chemokine cluster: dominance of inflammatory mediators over oncogenic alterations.

Leibovich-Rivkin T, Buganim Y, Solomon H, Meshel T, Rotter V, Ben-Baruch A.

Cancers (Basel). 2012 Jan 20;4(1):55-76. doi: 10.3390/cancers4010055.

20.

The Tumor-Promoting Flow of Cells Into, Within and Out of the Tumor Site: Regulation by the Inflammatory Axis of TNFα and Chemokines.

Ben-Baruch A.

Cancer Microenviron. 2012 Aug;5(2):151-64. doi: 10.1007/s12307-011-0094-3. Epub 2011 Dec 22.

21.

Transendothelial migration of lymphocytes mediated by intraendothelial vesicle stores rather than by extracellular chemokine depots.

Shulman Z, Cohen SJ, Roediger B, Kalchenko V, Jain R, Grabovsky V, Klein E, Shinder V, Stoler-Barak L, Feigelson SW, Meshel T, Nurmi SM, Goldstein I, Hartley O, Gahmberg CG, Etzioni A, Weninger W, Ben-Baruch A, Alon R.

Nat Immunol. 2011 Dec 4;13(1):67-76. doi: 10.1038/ni.2173.

PMID:
22138716
22.

Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition.

Soria G, Ofri-Shahak M, Haas I, Yaal-Hahoshen N, Leider-Trejo L, Leibovich-Rivkin T, Weitzenfeld P, Meshel T, Shabtai E, Gutman M, Ben-Baruch A.

BMC Cancer. 2011 Apr 12;11:130. doi: 10.1186/1471-2407-11-130.

24.

Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy.

Mishra P, Banerjee D, Ben-Baruch A.

J Leukoc Biol. 2011 Jan;89(1):31-9. doi: 10.1189/jlb.0310182. Epub 2010 Jul 13. Review.

PMID:
20628066
25.

Reduced expression of chemoattractant receptors by polymorphonuclear leukocytes in Hyper IgE Syndrome patients.

Mintz R, Garty BZ, Meshel T, Marcus N, Katanov C, Cohen-Hillel E, Ben-Baruch A.

Immunol Lett. 2010 May 4;130(1-2):97-106. doi: 10.1016/j.imlet.2009.12.006. Epub 2009 Dec 11.

PMID:
20005258
26.

Site-specific metastasis formation: chemokines as regulators of tumor cell adhesion, motility and invasion.

Ben-Baruch A.

Cell Adh Migr. 2009 Oct-Dec;3(4):328-33. Epub 2009 Oct 5. Review.

27.

Chemokines in human breast tumor cells: modifying their expression levels and determining their effects on the malignancy phenotype.

Soria G, Meshel T, Ben-Baruch A.

Methods Enzymol. 2009;460:3-16. doi: 10.1016/S0076-6879(09)05201-X.

PMID:
19446718
28.

Pneumocystis jirovecii pneumonia in a baby with hyper-IgE syndrome.

Garty BZ, Ben-Baruch A, Rolinsky A, Woellner C, Grimbacher B, Marcus N.

Eur J Pediatr. 2010 Jan;169(1):35-7. doi: 10.1007/s00431-009-0973-5. Epub 2009 Mar 24.

PMID:
19308447
29.

Cell migration to the chemokine CXCL8: paxillin is activated and regulates adhesion and cell motility.

Cohen-Hillel E, Mintz R, Meshel T, Garty BZ, Ben-Baruch A.

Cell Mol Life Sci. 2009 Mar;66(5):884-99. doi: 10.1007/s00018-009-8447-5.

PMID:
19151925
30.

Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.

Soria G, Yaal-Hahoshen N, Azenshtein E, Shina S, Leider-Trejo L, Ryvo L, Cohen-Hillel E, Shtabsky A, Ehrlich M, Meshel T, Keydar I, Ben-Baruch A.

Cytokine. 2008 Oct;44(1):191-200. doi: 10.1016/j.cyto.2008.08.002. Epub 2008 Sep 13.

PMID:
18790652
31.

The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells.

Nevo I, Sagi-Assif O, Meshel T, Ben-Baruch A, Jöhrer K, Greil R, Trejo LE, Kharenko O, Feinmesser M, Yron I, Witz IP.

Cancer Lett. 2009 Jan 8;273(1):127-39. doi: 10.1016/j.canlet.2008.07.029. Epub 2008 Sep 7.

PMID:
18778890
32.

The inflammatory chemokines CCL2 and CCL5 in breast cancer.

Soria G, Ben-Baruch A.

Cancer Lett. 2008 Aug 28;267(2):271-85. doi: 10.1016/j.canlet.2008.03.018. Epub 2008 Apr 24. Review.

PMID:
18439751
33.

Intracellular cross-talk between the GPCR CXCR1 and CXCR2: role of carboxyl terminus phosphorylation sites.

Attal H, Cohen-Hillel E, Meshel T, Wang JM, Gong W, Ben-Baruch A.

Exp Cell Res. 2008 Jan 15;314(2):352-65. Epub 2007 Sep 29.

PMID:
17996233
34.

Organ selectivity in metastasis: regulation by chemokines and their receptors.

Ben-Baruch A.

Clin Exp Metastasis. 2008;25(4):345-56. Epub 2007 Sep 21. Review.

PMID:
17891505
35.
36.

CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.

Zipin-Roitman A, Meshel T, Sagi-Assif O, Shalmon B, Avivi C, Pfeffer RM, Witz IP, Ben-Baruch A.

Cancer Res. 2007 Apr 1;67(7):3396-405.

37.

The multifaceted roles of chemokines in malignancy.

Ben-Baruch A.

Cancer Metastasis Rev. 2006 Sep;25(3):357-71. Review.

PMID:
17016763
38.

The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients.

Yaal-Hahoshen N, Shina S, Leider-Trejo L, Barnea I, Shabtai EL, Azenshtein E, Greenberg I, Keydar I, Ben-Baruch A.

Clin Cancer Res. 2006 Aug 1;12(15):4474-80. Review.

39.

CXCL8-induced FAK phosphorylation via CXCR1 and CXCR2: cytoskeleton- and integrin-related mechanisms converge with FAK regulatory pathways in a receptor-specific manner.

Cohen-Hillel E, Yron I, Meshel T, Soria G, Attal H, Ben-Baruch A.

Cytokine. 2006 Jan 7;33(1):1-16. Epub 2006 Jan 9.

PMID:
16406804
40.

Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11.

Dagan-Berger M, Feniger-Barish R, Avniel S, Wald H, Galun E, Grabovsky V, Alon R, Nagler A, Ben-Baruch A, Peled A.

Blood. 2006 May 15;107(10):3821-31. Epub 2005 Dec 20.

PMID:
16368892
41.

Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators.

Ben-Baruch A.

Semin Cancer Biol. 2006 Feb;16(1):38-52. Epub 2005 Aug 31. Review.

PMID:
16139507
42.

Cellular characteristics of neuroblastoma cells: regulation by the ELR--CXC chemokine CXCL10 and expression of a CXCR3-like receptor.

Goldberg-Bittman L, Sagi-Assif O, Meshel T, Nevo I, Levy-Nissenbaum O, Yron I, Witz IP, Ben-Baruch A.

Cytokine. 2005 Feb 7;29(3):105-17. Epub 2004 Dec 2.

PMID:
15613278
43.

The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors.

Azenshtein E, Meshel T, Shina S, Barak N, Keydar I, Ben-Baruch A.

Cancer Lett. 2005 Jan 10;217(1):73-86.

PMID:
15596298
44.

The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines.

Goldberg-Bittman L, Neumark E, Sagi-Assif O, Azenshtein E, Meshel T, Witz IP, Ben-Baruch A.

Immunol Lett. 2004 Mar 29;92(1-2):171-8.

PMID:
15081542
45.

The tumor microenvironment: CXCR4 is associated with distinct protein expression patterns in neuroblastoma cells.

Nevo I, Sagi-Assif O, Meshel T, Geminder H, Goldberg-Bittman L, Ben-Menachem S, Shalmon B, Goldberg I, Ben-Baruch A, Witz IP.

Immunol Lett. 2004 Mar 29;92(1-2):163-9.

PMID:
15081541
46.

Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors.

Neumark E, Sagi-Assif O, Shalmon B, Ben-Baruch A, Witz IP.

Int J Cancer. 2003 Oct 10;106(6):879-86.

47.

IL-8-induced migratory responses through CXCR1 and CXCR2: association with phosphorylation and cellular redistribution of focal adhesion kinase.

Feniger-Barish R, Yron I, Meshel T, Matityahu E, Ben-Baruch A.

Biochemistry. 2003 Mar 18;42(10):2874-86.

PMID:
12627953
49.

Breast carcinoma: a report on the potential usage of the CC chemokine RANTES as a marker for a progressive disease.

Wigler N, Shina S, Kaplan O, Luboshits G, Chaitchik S, Keydar I, Ben-Baruch A.

Isr Med Assoc J. 2002 Nov;4(11 Suppl):940-3.

PMID:
12455185
50.

Intracellular trafficking of human CXCR1 and CXCR2: regulation by receptor domains and actin-related kinases.

Matityahu E, Feniger-Barish R, Meshel T, Zaslaver A, Ben-Baruch A.

Eur J Immunol. 2002 Dec;32(12):3525-35.

Supplemental Content

Loading ...
Support Center